"Placebo Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
| Descriptor ID |
D015990
|
| MeSH Number(s) |
N05.715.350.350.625 N06.850.490.734.875
|
| Concept/Terms |
Placebo Effect- Placebo Effect
- Effect, Placebo
- Effects, Placebo
- Placebo Effects
|
Below are MeSH descriptors whose meaning is more general than "Placebo Effect".
Below are MeSH descriptors whose meaning is more specific than "Placebo Effect".
This graph shows the total number of publications written about "Placebo Effect" by people in this website by year, and whether "Placebo Effect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 3 | 4 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Placebo Effect" by people in Profiles.
-
Placebo nonresponders: An experimental investigation on their unreliability over time. J Pain. 2025 Mar; 28:104777.
-
Creating Placebo Nonresponders in the Lab. J Pain. 2024 04; 25(4):962-973.
-
Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review. BMJ Open. 2023 10 17; 13(10):e077243.
-
Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis. Pain. 2024 Jan 01; 165(1):29-43.
-
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. Int J Neuropsychopharmacol. 2022 10 25; 25(10):827-838.
-
Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone. Pain. 2023 05 01; 164(5):984-990.
-
What is the role of placebo in neurotherapeutics? Expert Rev Neurother. 2022 Jan; 22(1):15-25.
-
Thirty Years of Neuroscientific Investigation of Placebo and Nocebo: The Interesting, the Good, and the Bad. Annu Rev Pharmacol Toxicol. 2022 01 06; 62:323-340.
-
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial. J Hematol Oncol. 2021 08 28; 14(1):133.
-
Hypothalamic-Pituitary-Adrenal Activity in Adverse Events Reporting After Placebo Administration. Clin Pharmacol Ther. 2021 11; 110(5):1349-1357.